Welcome to ShireCanada.com
Shire Canada Inc. ("Shire Canada") and Shire Human Genetic Therapies (Canada)
Inc. ("Shire Human Genetic Therapies (Canada)") are wholly owned subsidiaries of
Shire plc, a global specialty biopharmaceutical company that works closely with
specialist physicians to develop and market medicines that improve the quality
of life for patients, their families and caregivers.
Shire focuses on attention deficit hyperactivity disorder (ADHD), human genetic
therapies, hereditary angioedema, as well as gastrointestinal and renal
Shire Canada is a proud member of Canada’s Research-Based
Pharmaceutical Companies (Rx&D). Shire Human Genetic Therapies (Canada) is a
proud member of BIOTECanada.
Shire Canada Inc.
2250 Alfred-Nobel Blvd
Saint-Laurent, QC H4S 2C9
Shire Human Genetic Therapies (Canada) Inc.
4120 Yonge Street, Suite 404
Toronto, Canada M2P 2B8